An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404

Clinical Lymphoma Myeloma & Leukemia 2026

View at publisher
Authors: Jonathon B. Cohen, Craig A. Portell, Mehdi Hamadani, Opeyemi Jegede, Catherine Diefenbach, Christopher Fletcher, Matthew Matasar, Daniel Landsburg, Suparna Mantha, Brad Kahl
DOI: 10.1016/j.clml.2026.04.025
Cited by: 1
References: 22

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments

Publication details

Journal / source
Clinical Lymphoma Myeloma & Leukemia
Publisher
Elsevier BV
Volume
26
Issue
7
Pages
465–473.e1
Publication date
4 May 2026
Language
EN